| Literature DB >> 32691604 |
Santiago Lopez1, Gene Decastro, Katlynn M Van Ogtrop1, Sindee Weiss-Domis1, Samuel R Anandan1, Christopher J Magalee1, Regina Roofeh2, Tara A Liberman2.
Abstract
As the spread of the novel coronavirus disease 2019 (COVID-19) continues worldwide, health care systems are facing increased demand with concurrent health care provider shortages. This increase in patient demand and potential for provider shortages is particularly apparent for palliative medicine, where there are already shortages in the provision of this care. In response to the developing pandemic, our Geriatrics and Palliative (GAP) Medicine team formulated a 2-team approach which includes triage algorithms for palliative consults as well as acute symptomatic management for both patients diagnosed with or under investigation (PUI) for COVID-19. These algorithms provided a delineated set of guidelines to triage patients in need of palliative services and included provisions for acute symptoms management and the protection of both the patient care team and the families of patients with COVID-19. These guidelines helped with streamlining care in times of crisis, providing care to those in need, supporting frontline staff with primary-level palliative care, and minimizing the GAP team's risk of infection and burnout during the rapidly changing pandemic response.Entities:
Keywords: COVID-19; novel coronavirus; palliative medicine; triage and symptoms algorithms
Mesh:
Year: 2020 PMID: 32691604 PMCID: PMC7375359 DOI: 10.1177/1049909120942494
Source DB: PubMed Journal: Am J Hosp Palliat Care ISSN: 1049-9091 Impact factor: 2.500
Figure 1.Algorithm for palliative care consult of patient with coronavirus disease 2019 (COVID-19) confirmed or patient under investigation (PUI) for COVID-19.
Figure 2.Algorithm for acute management of coronavirus disease 2019 (COVID-19) or patients under investigation (PUI) for COVID-19 in severe pain or dyspnea at the end of life (EOL).
* Comfort care is a non-specific term that does not define a treatment plan. Therefore, specific treatments such as intravenous fluids, antimicrobials, and other therapies should be continued unless otherwise define by goals of care (GOC).
** Pain Assessment in Advanced Dementia Scale (PAIN AD) and Respiratory Distress Observation Scale (RDOS).
*** Opioid equi-analgesic table as per individual institutional consensus.
**** In patients with normal renal or hepatic function, adjusting the continues infusion at 8-12 hours (about five half-lives) is generally acceptable, as the drug will be close to or at steady state. If there is organ impairment, it is reasonable to wait up to 24 hours.
PUI= Patient under investigation.
Baseline Characteristics of Operational Metrics for GAP Consult Team Prior to COVID-19 Versus March 23 and April 23, 2020 (Peak of COVID-19 in New York).
| Operational metric | Average no. prior to COVID-19 | Average no. March 23-April 23, 2020 |
|---|---|---|
| No. consult per month | 202 | 305 |
| Admission to consult | 6.5 | 6.9 |
| Consult to discharge | 11.1 | 7 |
| LOSa | 18 | 13.6 |
| All mortality, (%) | 38 | 69.5 |
| Discharge to hospice, (%) | 4 | 8.5 |
Abbreviations: COVID-19, coronavirus disease 2019; GAP, geriatrics and palliative; LOS, length of stay.
aLength of stay begins with admission time and ends with discharge time, time at death, or midnight on the last day of data collection for the study. It does not include time in the emergency department.